Recall of SHILEY LOW PRESSURE CUFFED TRACHEOSTOMY TUBE

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by COVIDIEN.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    48488
  • Event Risk Class
    I
  • Event Initiated Date
    2012-07-19
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Certain size 8 shiley reusable cannula cuffed tracheostomy tubes have volume leakage and/or disconnection between the inner and outer cannulae.

Device

  • Model / Serial
    Model Catalog: LPC (Lot serial: from 110200327X to 120600351X); Model Catalog: FEN (Lot serial: from 110200327X to 120600351X); Model Catalog: LPC (Lot serial: from 0910000346 to 1101001823); Model Catalog: FEN (Lot serial: from 0910000346 to 1101001823); Model Catalog: LPC (Lot serial: from 110201893X to 120600700X); Model Catalog: FEN (Lot serial: from 110201893X to 120600700X); Model Catalog: LPC (Lot serial: from 0910000342 to 1101001558); Model Catalog: FEN (Lot serial: from 0910000342 to 1101001558)
  • Product Description
    Shiley Low Pressure Cuffed Tracheostomy Tube 8 FEN /LPC
  • Manufacturer

Manufacturer

  • Manufacturer Address
    SAINT-LAURENT
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    HC